Salles Paula Ferreira, Perce-da-Silva Daiana Souza, Rossi Atila Duque, Raposo Luisa Riehl, Ramirez Ramirez Aina Danaisa, Pereira Bastos Otílio Machado, Pratt-Riccio Lilian Rose, Cassiano Gustavo Capatti, Baptista Andrea Regina Souza, Cardoso Cynthia Chester, Banic Dalma Maria, Machado Ricardo Luiz Dantas
Centro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Faculdade de Medicina de Petrópolis, Petrópolis, Brazil.
Front Pharmacol. 2021 Jul 23;12:542342. doi: 10.3389/fphar.2021.542342. eCollection 2021.
Genetic variability was linked with individual responses to treatment and susceptibility to malaria by . Polymorphisms in the 2D6 gene may modulate enzyme level and activity, thereby affecting individual responses to pharmacological treatment. The aim of the study was to investigate whether or not 2D6 single nucleotide polymorphisms rs1065852, rs38920-97, rs16947 and rs28371725 are unequally distributed in malaria by individuals from the Brazilian Amazon region. The blood samples were collected from 220 unrelated patients from five different endemic areas. Genotyping was performed using SNaPshot and real-time polymerase chain reaction methods. In all five areas, the rs1065852 (2D610, C.100C > T), rs3892097 (2D64, 1846C > T) and rs16947 (2D62, C.2850G > A), as a homozygous genotype, showed the lowest frequencies. The rs28371725 (2D641, 2988G > A) homozygous genotype was not detected, while the allele A was found in a single patient from Macapá region. No deviations from Hardy-Weinberg equilibrium were found, although a borderline -value was observed ( = 0.048) for the SNP rs3892097 in Goianésia do Pará, Pará state. No significant associations were detected in these frequencies among the five studied areas. For the SNP rs3892097, a higher frequency was observed for the C/T heterozygous genotype in the Plácido de Castro and Macapá, Acre and Amapá states, respectively. The distribution of the 2D6 alleles investigated in the different areas of the Brazilian Amazon is not homogeneous. Further investigations are necessary in order to determine which alleles might be informative to assure optimal drug dosing recommendations based on experimental pharmacogenetics.
基因变异性与个体对治疗的反应以及对疟疾的易感性相关。2D6基因的多态性可能会调节酶的水平和活性,从而影响个体对药物治疗的反应。本研究的目的是调查2D6单核苷酸多态性rs1065852、rs38920 - 97、rs16947和rs28371725在巴西亚马逊地区疟疾患者中是否分布不均。从五个不同流行地区的220名无亲缘关系的患者中采集血样。使用SNaPshot和实时聚合酶链反应方法进行基因分型。在所有五个地区,rs1065852(2D610,C.100C>T)、rs3892097(2D64,1846C>T)和rs16947(2D62,C.2850G>A)作为纯合基因型,显示出最低的频率。未检测到rs28371725(2D641,2988G>A)纯合基因型,而等位基因A仅在来自马卡帕地区的一名患者中发现。尽管在帕拉州戈亚内西亚多帕拉的SNP rs3892097观察到一个临界p值(p = 0.048),但未发现偏离哈迪 - 温伯格平衡的情况。在五个研究地区的这些频率之间未检测到显著关联。对于SNP rs3892097,在普拉西多·德卡斯特罗以及阿克里州和阿马帕州的马卡帕,分别观察到C/T杂合基因型的频率较高。在巴西亚马逊不同地区研究的2D6等位基因分布并不均匀。有必要进行进一步调查,以确定哪些等位基因可能有助于根据实验药物遗传学确定最佳给药建议。